Skip to main content

Anthony Vecchione

By Anthony Vecchione | 01:55 pm | November 07, 2025
OpenEvidence will integrate content from the NCCN guidelines in oncology into its clinician-facing AI platform.
By Anthony Vecchione | 02:10 pm | November 06, 2025
The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.
By Anthony Vecchione | 11:43 am | November 04, 2025
The increase in adjusted gross margin was related to a rise in average selling price and a decrease in software amortization costs for the company's software development investments.
By Anthony Vecchione | 11:32 am | November 04, 2025
Innovaccer’s healthcare data unification and analytics will be combined with Tawuniya’s experience in health insurance and risk management.
By Anthony Vecchione | 11:11 am | November 04, 2025
Cheney said that the MedTech tax was a barrier to medical innovation.
By Anthony Vecchione | 10:57 am | November 03, 2025
Dream Sight monitors a baby's pulse rate, oxygen level, and sleep and wellness trends.
By Anthony Vecchione | 01:04 pm | October 31, 2025
The company says it is seeing an increased demand for testosterone hormone treatment.
By Anthony Vecchione | 02:41 pm | October 30, 2025
The funds will be used to increase the company's development into new automated orthopedic indications and deploy its manufacturing model.
By Anthony Vecchione | 02:05 pm | October 30, 2025
The company will use the funds to broaden its product line and boost recruitment.
By Anthony Vecchione | 01:52 pm | October 29, 2025
By teaming up with Fivetran, Hippocratic AI will be able to reproduce its customer data in an analytical environment.